1.6 billion last yr. Baxter International Inc., located in Deerfield, Illinois, said dialysis treatment rates are increasing each year by more than 5 percent, partly due to growing rates of diabetes and high blood circulation pressure. More than 2 million people are on some type of dialysis globally. Dialysis involves removing blood from an individual, running it through a machine that cleans out impurities and then returning it to the patient’s body.
Baxter’s medical device division makes products for kidney dialysis and intravenous administration pieces to deliver medications and fluids to patients. Baxter also offers a bioscience division that make vaccines and high-tech treatments for hemophilia and other bleeding disorders, burns and shock, immune system deficiencies, and other blood-related conditions. Baxter will pay for the deal with a combination of cash and debt generated from overseas operations.
It needs the acquisition to close in the first fifty percent of next 12 months. 4 billion, keeping track of debt. The Wall Street Journal reported last month that Baxter was negotiating to buy Gambro. Gambro is owned in part by Investor AB, the Swedish investment group controlled by the Wallenberg family. Copyright 2012 The Associated Press. All privileges reserved. This material might not be published, broadcast, rewritten, or redistributed.
That’s all about some important things every NRI, PIO, or any Indian living outside India should know and remember. These exact things are quite common, and I am certain many of you know them but I have lots of friends and colleagues who …